You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 159 No. 16, September 13, 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (11)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Cocaine-Induced Erythrocytosis and Increase in von Willebrand Factor

Evidence for Drug-Related Blood Doping and Prothrombotic Effects

Arthur J. Siegel, MD; Michelle B. Sholar, BA; Jack H. Mendelson, MD; Scott E. Lukas, PhD; Marc J. Kaufman, PhD; Perry F. Renshaw, MD, PhD; Jane C. McDonald, RP; Kent B. Lewandrowski, MD; Fred S. Apple, PhD; James J. Stec, BS; Izabella Lipinska, PhD; Geoffrey H. Tofler, MD; Paul M. Ridker, MD

Arch Intern Med. 1999;159:1925-1929.

Background  Mechanisms that mediate cocaine-induced cardiovascular events following vasoconstriction are incompletely understood.

Objective  To examine the effects of cocaine in moderate doses on hematologic and hemostatic parameters that influence blood viscosity and thrombotic potential.

Methods  Changes in hemoglobin concentration, hematocrit, and red blood cell counts were measured in human subjects who met Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria for long-term cocaine abuse, before and sequentially after moderate intranasal and intravenous doses of cocaine. Hemostatic parameters, including von Willebrand factor, fibrinolytic activity, fibrinogen, plasminogen activator inhibitor antigen, and tissue-type plasminogen activator antigen, were sequentially measured after intravenous cocaine or saline placebo with cardiac troponin subunits T and I.

Results  Hemoglobin level (P=.002), hematocrit (P=.01), and red blood cell counts (P=.04) significantly increased from 4% to 6% over baseline from 10 to 30 minutes after intranasal (n=14) and intravenous (n=7) cocaine administration in doses of 0.9 mg/kg and 0.4 mg/kg, respectively, with no change in white blood cell or platelet counts. There was a significant increase (P=.03) in von Willebrand factor from 30 to 240 minutes, peaking at 40% over baseline following intravenous cocaine administration in a dose of 0.4 mg/kg (n=12), with no change after 0.2 mg/kg (n=3) or placebo (n=6). Other hemostatic factors, creatinine, blood urea nitrogen, and cardiac troponin subunits T and I showed no changes.

Conclusions  Cocaine induced a transient erythrocytosis that may increase blood viscosity while maintaining tissue oxygenation during vasoconstriction. An increase in von Willebrand factor without a compensatory change in endogenous fibrinolysis may trigger platelet adhesion, aggregation, and intravascular thrombosis.


From the Department of Medicine (Dr Siegel), Alcohol and Drug Abuse Research Center (Ms Sholar and Drs Mendelson and Lukas), Brain Imaging Center (Drs Kaufman and Renshaw), and Pharmacy Department (Ms McDonald), McLean Hospital, Belmont, Mass; Department of Clinical Laboratory, Massachusetts General Hospital, Boston (Dr Lewandrowski); Department of Laboratories, Hennepin County Medical Center and University of Minnesota School of Medicine, Minneapolis (Dr Apple); Institute for the Prevention of Cardiovascular Disease, Beth Israel-Deaconess Medical Center, Boston (Mr Stec and Dr Lipinska); Royal North Shore Hospital, Sydney, Australia (Dr Tofler); Department of Cardiology, Brigham and Women's Hospital, Boston (Dr Ridker); and Harvard Medical School, Boston (Drs Siegel, Mendelson, Lukas, Kaufman, Renshaw, Lewandrowski, and Ridker).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Triggering of Acute Cardiovascular Disease and Potential Preventive Strategies
Tofler and Muller
Circulation 2006;114:1863-1872.
FULL TEXT  

Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.
Goldstein et al.
Circulation 2006;113:e873-e923.
ABSTRACT | FULL TEXT  

Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.
Goldstein et al.
Stroke 2006;37:1583-1633.
ABSTRACT | FULL TEXT  

Increased Prevalence of Coronary Artery Aneurysms Among Cocaine Users
Satran et al.
Circulation 2005;111:2424-2429.
ABSTRACT | FULL TEXT  

Acute Respiratory Failure from Abused Substances
Wilson and Saukkonen
J Intensive Care Med 2004;19:183-193.
ABSTRACT  

Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association
Goldstein et al.
Circulation 2001;103:163-182.
FULL TEXT  

Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association
Goldstein et al.
Stroke 2001;32:280-299.
FULL TEXT  

Acute Aortic Dissection Related to Crack Cocaine
Hsue et al.
Circulation 2002;105:1592-1595.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.